FilingSEC EDGAR8-K
Sunshine Biopharma Director Andrew Keller Will Not Seek Reelection
· SEC accepted
StageDirector Departure
Filing content
Sunshine Biopharma director Dr. Andrew Keller has notified the company that he will not seek reelection upon the completion of his current term.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…